Sun Pharma share price falls over 4%

Sun Pharma share price declined more than 4% on Friday after the drug major reported its Q4 results. Sun Pharma shares fell as much as 4.86% to ₹1,636.30 apiece on the BSE. Sun Pharmaceutical Industries reported a consolidated net profit of ₹2,154 crore in the fourth quarter of FY25, registering a decline of 19% from ₹2,659 crore in the year ago period. The company’s revenue from operations in Q4FY25 increased 8% to ₹12,959 crore from ₹11,983 crore, year-on-year (YoY). Sun Pharma's India formulation sales rose 13.6% YoY in Q4FY25 to ₹4,213 crore, while US formulation sales came at $464 million, down 2.5%YoY during the quarter.